Rockbridge Investment Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Rockbridge Investment Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-425	Closed	-$22K	–	764
2021 Q2	$22K	Sell	425 -400	-48%	-$20.1K	﹤0.01%	432
2021 Q1	$42K	Hold	825	–	–	0.01%	315
2020 Q4	$43K	Buy	825 +5	+0.6%	+$239	0.01%	304
2020 Q3	$36K	Buy	820 +810	+8,100%	+$35.5K	0.01%	306
2020 Q2	$0	Buy	+10	New	+$413	﹤0.01%	641

Other funds holding XPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Rockbridge Investment Management's XPH Position: Q3 2021 in Review

Rockbridge Investment Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2021, closing a stake of 425 shares — an estimated $22K sold.

Rockbridge Investment Management first reported a position in XPH in Q2 2020 and held it in 5 quarters. The position peaked at $43K in Q4 2020. 78 funds tracked by Wall St. Rank hold XPH as of Q3 2021.

Rockbridge Investment Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2021 after selling out during the quarter.
Rockbridge Investment Management sold 425 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2021, an estimated $22K.
Rockbridge Investment Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2020 and held it in 5 quarters.
Rockbridge Investment Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $43K in Q4 2020.
78 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2021.

Based on Rockbridge Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.